Federated Hermes’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.9K Sell
1,709
-434
-20% -$3.53K ﹤0.01% 1765
2025
Q1
$16.8K Sell
2,143
-750
-26% -$5.89K ﹤0.01% 1750
2024
Q4
$43.1K Sell
2,893
-285
-9% -$4.24K ﹤0.01% 1707
2024
Q3
$48.6K Buy
+3,178
New +$48.6K ﹤0.01% 1668
2023
Q4
Sell
-1,095
Closed -$19.7K 2179
2023
Q3
$19.7K Sell
1,095
-38,273
-97% -$687K ﹤0.01% 1766
2023
Q2
$800K Buy
39,368
+34,915
+784% +$709K ﹤0.01% 1210
2023
Q1
$81.2K Buy
4,453
+2,203
+98% +$40.2K ﹤0.01% 1690
2022
Q4
$46.5K Buy
2,250
+126
+6% +$2.61K ﹤0.01% 1721
2022
Q3
$56K Buy
+2,124
New +$56K ﹤0.01% 1658
2022
Q2
Sell
-3,541
Closed -$111K 2255
2022
Q1
$111K Sell
3,541
-10,137
-74% -$318K ﹤0.01% 1651
2021
Q4
$553K Buy
13,678
+8,205
+150% +$332K ﹤0.01% 1455
2021
Q3
$191K Buy
5,473
+5,217
+2,038% +$182K ﹤0.01% 1669
2021
Q2
$7K Sell
256
-189,137
-100% -$5.17M ﹤0.01% 2011
2021
Q1
$5.32M Buy
189,393
+188,881
+36,891% +$5.3M 0.01% 836
2020
Q4
$13K Sell
512
-116,773
-100% -$2.96M ﹤0.01% 1950
2020
Q3
$2.01M Buy
117,285
+65,060
+125% +$1.11M ﹤0.01% 985
2020
Q2
$1.29M Sell
52,225
-45,182
-46% -$1.12M ﹤0.01% 1155
2020
Q1
$1.35M Buy
97,407
+91,309
+1,497% +$1.27M ﹤0.01% 1015
2019
Q4
$62K Sell
6,098
-407
-6% -$4.14K ﹤0.01% 1719
2019
Q3
$59K Sell
6,505
-82
-1% -$744 ﹤0.01% 1704
2019
Q2
$53K Buy
6,587
+840
+15% +$6.76K ﹤0.01% 1667
2019
Q1
$72K Buy
5,747
+2,038
+55% +$25.5K ﹤0.01% 1622
2018
Q4
$40K Sell
3,709
-232
-6% -$2.5K ﹤0.01% 1682
2018
Q3
$55K Buy
+3,941
New +$55K ﹤0.01% 1725